Florida schools join nationwide lawsuit against Juul e-cigarettes.

Oct.12.2022

Florida schools join nationwide lawsuit against Juul for targeting underage users with e-cigarettes. Over 1300 districts involved.

Panama City, Florida (WJHG/WECP) - Gulf Coast schools are joining a nationwide lawsuit against e-cigarette company Juul.

Approximately 1,300 American school districts, including several in Florida, are participating in this pollution lawsuit. The goal is to hold JUUL accountable for the use of their respiratory devices by minors.

This survey will take only a few hours within the school district, but could yield a significant amount of funds for improving school resources.

Franklin Harrison, the lawyer for the Gulf Area School Board, stated, "This is a huge issue within our schools. It's a problem that administrators and teachers have to deal with across the country regularly. It's important for them to be aware of what they're doing in terms of marketing.

The first trial is scheduled to take place on November 4 in San Francisco.

Statement:

This article is compiled from third-party information and is intended solely for industry communications and learning.

This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.

Due to limitations in the compiler's ability, the translated article may not fully express the original text. Please refer to the original article for accuracy.

2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.

The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.

#Juul #E-cigarette #E-cigarettes and Tobacco

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

France proposes tax on e-liquid in latest budget plan: 30 to 50 euro cents per 10 ml bottle

France to introduce tax on e-cigarette liquid in new budget proposal, with rates ranging from 30 to 50 euro cents per 10ml.

Oct.15 by 2FIRSTS.ai

62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds

Vape retailer Haypp reports that 62.5% of vapers still use disposable vapes, rising to 82% among those aged 25–34. 35% of disposable users say they are still buying disposables. Black-market purchases reportedly come mainly from local smaller shops (55%) and specialist vape stores (37%), as well as supermarkets, online retailers and car boot sales. 78.5% of respondents are using pre-ban stock, posing safety risks from aging lithium-ion batteries; 14% plan to continue buying disposables,.

Oct.23 by 2FIRSTS.ai

Spanish Police Seize Over 24,000 Smuggled E-Cigarettes; Two Arrested on Multiple Charges

The Spanish Civil Guard carried out an operation targeting e-cigarette smuggling and illegal distribution, seizing a total of 24,520 e-cigarettes of unknown origin valued at approximately €312,000.

Oct.10 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai